Cumberland Pharmaceuticals Inc (CPIX) income statement
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30225% above fair value
$5.80+0.59 (+11.32%)
Close on Nov 17, 2026Market cap $86.90MP/E –Yield –
Cumberland Pharmaceuticals Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 121.1%
- Operating margin
- -30.8%
- Net margin
- -34.9%
- Return on equity, FY2025
- -11.9%
Financial strength
- Current ratio
- 0.96
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 11.0%
Valuation
- P/E ratio
- –
- Price to sales
- 2.78
- Price to book
- 4.98
- Dividend yield
- –
See a number that looks wrong?